Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Jan 2023 for Aveo Pharmaceuticals, INC., €227k.
Filing timeline
BuySaleMichael Ferraresso
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Ferraresso: trading record in brief
Michael Ferraresso is a declared insider of Aveo Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 10 August 2021 to 19 January 2023.
Every open-market trade on record is a purchase: 1 purchase worth €13k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 19 January 2023 with a transaction (€227k) in Aveo Pharmaceuticals, Inc. The most recent open-market purchase was published on 11 August 2021, 1,900 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Ferraresso
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
16,345 shares@ US$15.0089.9% of flowCommon StockSEC:0000899243-23-002191:0
2,608 shares@ US$5.755.3% of flowCommon StockSEC:0000899243-21-032613:0
Canonical exit: 8 Nov 2021 (T+90)
2 of 2 declarations
